Just days after President announced tariffs on drug imports!

Breitbart

Pharmaceutical company Novartis announced plans to build seven facilities in the United States and expand others in a $23 billion investment over five years on the heels of President Donald Trump’s announcement of forthcoming tariffs on imported drugs.

The Swiss company revealed the major investment in a press release.

“This commitment enables Novartis to expand on its current manufacturing, research and technology presence across the country with 10 facilities, including 7 brand new facilities, creating nearly 1,000 new jobs at Novartis and approximately 4,000 additional US jobs,” the release said.

Six of the facilities will be manufacturing plants, two of which will focus on radioligand therapy in Florida and Texas. It remains to be seen where the other four plants will be built.

Moreover, the company is establishing a biomedical research innovation center in San Diego as part of the investment, and it is expanding three of its production facilities in Indiana, New Jersey, and California.

The company also noted that its goal is to ensure “all key Novartis medicines for US patients will be made in the United States.”